Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Intravenous infusion of mesenchymal stem cells improves impaired cognitive function in a cerebral small vessel disease model.

Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Oka S, Suzuki J, Sasaki Y, Nagahama H, Hashi K, Kocsis JD, Honmou O.

Neuroscience. 2019 Jun 1;408:361-377. doi: 10.1016/j.neuroscience.2019.04.018. Epub 2019 Apr 16.

PMID:
30999031
2.

Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction.

Namioka T, Namioka A, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Kocsis JD, Honmou O.

J Neurosurg. 2018 Oct 1:1-8. doi: 10.3171/2018.5.JNS18140. [Epub ahead of print]

PMID:
30485210
3.

Intravenous infusion of mesenchymal stem cells for protection against brainstem infarction in a persistent basilar artery occlusion model in the adult rat.

Namioka A, Namioka T, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Kocsis JD, Honmou O.

J Neurosurg. 2018 Oct 1:1-9. doi: 10.3171/2018.4.JNS173121. [Epub ahead of print]

PMID:
30485204
4.

Detection of local and remote cellular damage caused by spinal cord and peripheral nerve injury using a heat shock signaling reporter system.

Hashimoto-Torii K, Sasaki M, Chang YW, Hwang H, Waxman SG, Kocsis JD, Rakic P, Torii M.

IBRO Rep. 2018 Nov 6;5:91-98. doi: 10.1016/j.ibror.2018.11.003. eCollection 2018 Dec.

5.

Functional recovery after the systemic administration of mesenchymal stem cells in a rat model of neonatal hypoxia-ischemia.

Sakai T, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Fukumura S, Kobayashi M, Tsutsumi H, Kocsis JD, Honmou O.

J Neurosurg Pediatr. 2018 Nov 1;22(5):513-522. doi: 10.3171/2018.5.PEDS1845.

PMID:
30074448
6.

Actin, alpha, cardiac muscle 1 (ACTC1) knockdown inhibits the migration of glioblastoma cells in vitro.

Wanibuchi M, Ohtaki S, Ookawa S, Kataoka-Sasaki Y, Sasaki M, Oka S, Kimura Y, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O.

J Neurol Sci. 2018 Sep 15;392:117-121. doi: 10.1016/j.jns.2018.07.013. Epub 2018 Jul 17.

PMID:
30055382
7.

Preservation of interhemispheric cortical connections through corpus callosum following intravenous infusion of mesenchymal stem cells in a rat model of cerebral infarction.

Nagahama H, Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Namioka T, Namioka A, Oka S, Onodera R, Suzuki J, Sasaki Y, Kocsis JD, Honmou O.

Brain Res. 2018 Sep 15;1695:37-44. doi: 10.1016/j.brainres.2018.05.033. Epub 2018 May 23.

PMID:
29802840
8.

Postirradiation Necrosis after Slow Microvascular Breakdown in the Adult Rat Spinal Cord is Delayed by Minocycline Treatment.

Lankford KL, Arroyo EJ, Kocsis JD.

Radiat Res. 2018 Aug;190(2):151-163. doi: 10.1667/RR15039.1. Epub 2018 May 25.

PMID:
29799318
9.

Intravenous infusion of mesenchymal stem cells reduces epileptogenesis in a rat model of status epilepticus.

Fukumura S, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Nagahama H, Morita T, Sakai T, Tsutsumi H, Kocsis JD, Honmou O.

Epilepsy Res. 2018 Mar;141:56-63. doi: 10.1016/j.eplepsyres.2018.02.008. Epub 2018 Feb 14.

PMID:
29475054
10.

Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma.

Ookawa S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Ohtaki S, Noshiro S, Komatsu K, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O.

World Neurosurg. 2018 Mar;111:e783-e789. doi: 10.1016/j.wneu.2017.12.166. Epub 2018 Jan 5.

PMID:
29309973
11.

Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord.

Lankford KL, Arroyo EJ, Nazimek K, Bryniarski K, Askenase PW, Kocsis JD.

PLoS One. 2018 Jan 2;13(1):e0190358. doi: 10.1371/journal.pone.0190358. eCollection 2018.

12.

Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Erectile Dysfunction Following Cavernous Nerve Injury in Rats.

Matsuda Y, Sasaki M, Kataoka-Sasaki Y, Takayanagi A, Kobayashi K, Oka S, Nakazaki M, Masumori N, Kocsis JD, Honmou O.

Sex Med. 2018 Mar;6(1):49-57. doi: 10.1016/j.esxm.2017.10.005. Epub 2017 Dec 21.

13.

Chronic TNF╬▒ Exposure Induces Robust Proliferation of Olfactory Ensheathing Cells, but not Schwann Cells.

Lankford KL, Arroyo EJ, Kocsis JD.

Neurochem Res. 2017 Sep;42(9):2595-2609. doi: 10.1007/s11064-017-2285-x. Epub 2017 May 11.

PMID:
28497341
14.

Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.

Nakamura H, Sasaki Y, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Namioka T, Namioka A, Onodera R, Suzuki J, Nagahama H, Mikami T, Wanibuchi M, Kocsis JD, Honmou O.

J Neurosurg Sci. 2019 Feb;63(1):42-49. doi: 10.23736/S0390-5616.17.03989-3. Epub 2017 Feb 8.

PMID:
28181779
15.

Detection of vulnerable neurons damaged by environmental insults in utero.

Torii M, Sasaki M, Chang YW, Ishii S, Waxman SG, Kocsis JD, Rakic P, Hashimoto-Torii K.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2367-2372. doi: 10.1073/pnas.1620641114. Epub 2017 Jan 25.

16.

Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations.

Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Ohnishi H, Ohtaki S, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O.

J Clin Neurosci. 2017 Mar;37:83-90. doi: 10.1016/j.jocn.2016.12.023. Epub 2017 Jan 10.

PMID:
28087183
17.

Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.

Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Oka S, Namioka T, Namioka A, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Mikami T, Wanibuchi M, Kocsis JD, Honmou O.

J Neurosurg. 2017 Oct;127(4):917-926. doi: 10.3171/2016.8.JNS16240. Epub 2017 Jan 6.

PMID:
28059661
18.

Synergic Effects of Rehabilitation and Intravenous Infusion of Mesenchymal Stem Cells After Stroke in Rats.

Sasaki Y, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Suzuki J, Tateyama D, Oka S, Namioka T, Namioka A, Onodera R, Mikami T, Wanibuchi M, Kakizawa M, Ishiai S, Kocsis JD, Honmou O.

Phys Ther. 2016 Nov;96(11):1791-1798. Epub 2016 May 12.

PMID:
27174259
19.

Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury.

Morita T, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Oka S, Oshigiri T, Takebayashi T, Yamashita T, Kocsis JD, Honmou O.

Neuroscience. 2016 Oct 29;335:221-31. doi: 10.1016/j.neuroscience.2016.08.037. Epub 2016 Aug 30.

PMID:
27586052
20.

Biological relevance of tissue factor and IL-6 in arteriovenous malformations.

Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Hashi K, Ohtaki S, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O.

Neurosurg Rev. 2017 Jul;40(3):359-367. doi: 10.1007/s10143-016-0780-1. Epub 2016 Aug 19.

PMID:
27542852
21.

ACTC1 as an invasion and prognosis marker in glioma.

Ohtaki S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Noshiro S, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O.

J Neurosurg. 2017 Feb;126(2):467-475. doi: 10.3171/2016.1.JNS152075. Epub 2016 Apr 15.

PMID:
27081897
22.

Intravenous Preload of Mesenchymal Stem Cells Rescues Erectile Function in a Rat Model of Cavernous Nerve Injury.

Takayanagi A, Sasaki M, Kataoka-Sasaki Y, Kobayashi K, Matsuda Y, Oka S, Masumori N, Kocsis JD, Honmou O.

J Sex Med. 2015 Aug;12(8):1713-21. doi: 10.1111/jsm.12957. Epub 2015 Jul 24.

PMID:
26211660
23.

Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells.

Matsushita T, Lankford KL, Arroyo EJ, Sasaki M, Neyazi M, Radtke C, Kocsis JD.

Exp Neurol. 2015 May;267:152-64. doi: 10.1016/j.expneurol.2015.03.001. Epub 2015 Mar 12.

PMID:
25771801
24.

Olfactory-ensheathing cell transplantation for peripheral nerve repair: update on recent developments.

Radtke C, Kocsis JD.

Cells Tissues Organs. 2014;200(1):48-58. doi: 10.1159/000369006. Epub 2015 Mar 4. Review.

PMID:
25765445
25.

Intravenous mesenchymal stem cell therapy after recurrent laryngeal nerve injury: a preliminary study.

Lerner MZ, Matsushita T, Lankford KL, Radtke C, Kocsis JD, Young NO.

Laryngoscope. 2014 Nov;124(11):2555-60. doi: 10.1002/lary.24798. Epub 2014 Jul 7.

PMID:
25043703
26.

Intravenous transplantation of mesenchymal stromal cells to enhance peripheral nerve regeneration.

Matthes SM, Reimers K, Janssen I, Liebsch C, Kocsis JD, Vogt PM, Radtke C.

Biomed Res Int. 2013;2013:573169. doi: 10.1155/2013/573169. Epub 2013 Dec 26.

27.

Olfactory ensheathing cells, but not Schwann cells, proliferate and migrate extensively within moderately X-irradiated juvenile rat brain.

Lankford KL, Brown RJ, Sasaki M, Kocsis JD.

Glia. 2014 Jan;62(1):52-63. doi: 10.1002/glia.22583. Epub 2013 Oct 24.

PMID:
24166823
28.

Sural nerve defects after nerve biopsy or nerve transfer as a sensory regeneration model for peripheral nerve conduit implantation.

Radtke C, Kocsis JD, Reimers K, Allmeling C, Vogt PM.

Med Hypotheses. 2013 Sep;81(3):500-2. doi: 10.1016/j.mehy.2013.06.020. Epub 2013 Jul 16.

PMID:
23867139
29.

Sciatic nerve regeneration is not inhibited by anti-NGF antibody treatment in the adult rat.

Lankford KL, Arroyo EJ, Liu CN, Somps CJ, Zorbas MA, Shelton DL, Evans MG, Hurst SI, Kocsis JD.

Neuroscience. 2013 Jun 25;241:157-69. doi: 10.1016/j.neuroscience.2013.03.024. Epub 2013 Mar 24.

PMID:
23531437
30.

Paracrine loop of keratinocyte proliferation and directed neuritic outgrowth in a neuroepithelial coculture.

Radtke C, Rennekampff HO, Reimers K, Vogt PM, Kocsis JD.

Ann Plast Surg. 2013 Feb;70(2):162-7. doi: 10.1097/SPA.0b013e318276d946.

PMID:
23328123
31.

Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model.

Suzuki J, Sasaki M, Harada K, Bando M, Kataoka Y, Onodera R, Mikami T, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O.

Brain Res. 2013 Feb 25;1497:15-22. doi: 10.1016/j.brainres.2012.12.028. Epub 2012 Dec 27.

PMID:
23274536
32.

Peripheral nerve injuries and transplantation of olfactory ensheathing cells for axonal regeneration and remyelination: fact or fiction?

Radtke C, Kocsis JD.

Int J Mol Sci. 2012 Oct 10;13(10):12911-24. doi: 10.3390/ijms131012911. Review.

33.

Bone marrow stem cells in experimental stroke.

Kocsis JD, Honmou O.

Prog Brain Res. 2012;201:79-98. doi: 10.1016/B978-0-444-59544-7.00005-6. Review.

PMID:
23186711
34.

Mesenchymal stem cells: therapeutic outlook for stroke.

Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD.

Trends Mol Med. 2012 May;18(5):292-7. doi: 10.1016/j.molmed.2012.02.003. Epub 2012 Mar 27. Review.

PMID:
22459358
35.

CNPase expression in olfactory ensheathing cells.

Radtke C, Sasaki M, Lankford KL, Gallo V, Kocsis JD.

J Biomed Biotechnol. 2011;2011:608496. doi: 10.1155/2011/608496. Epub 2011 Nov 16.

36.

Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.

Sasaki M, Honmou O, Radtke C, Kocsis JD.

PLoS One. 2011;6(10):e26577. doi: 10.1371/journal.pone.0026577. Epub 2011 Oct 24.

37.

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, Waxman SG, Kocsis JD.

Brain. 2011 Jun;134(Pt 6):1790-807. doi: 10.1093/brain/awr063. Epub 2011 Apr 14.

38.

Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments.

Sasaki M, Lankford KL, Radtke C, Honmou O, Kocsis JD.

Exp Neurol. 2011 May;229(1):88-98. doi: 10.1016/j.expneurol.2011.01.010. Epub 2011 Jan 28. Review.

PMID:
21281634
39.
40.

Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome.

Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, Kocsis JD.

Brain Res. 2010 Jul 9;1343:226-35. doi: 10.1016/j.brainres.2010.05.011. Epub 2010 May 12.

PMID:
20470759
41.

Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.

Komatsu K, Honmou O, Suzuki J, Houkin K, Hamada H, Kocsis JD.

Brain Res. 2010 Jun 2;1334:84-92. doi: 10.1016/j.brainres.2010.04.006. Epub 2010 Apr 9.

PMID:
20382136
42.

Impaired spinal cord remyelination by long-term cultured adult porcine olfactory ensheathing cells correlates with altered in vitro phenotypic properties.

Radtke C, Lankford KL, Wewetzer K, Imaizumi T, Fodor WL, Kocsis JD.

Xenotransplantation. 2010 Jan-Feb;17(1):71-80. doi: 10.1111/j.1399-3089.2009.00562.x.

PMID:
20149190
43.

Pathology of blast-related brain injury.

Kocsis JD, Tessler A.

J Rehabil Res Dev. 2009;46(6):667-72.

44.

BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury.

Sasaki M, Radtke C, Tan AM, Zhao P, Hamada H, Houkin K, Honmou O, Kocsis JD.

J Neurosci. 2009 Nov 25;29(47):14932-41. doi: 10.1523/JNEUROSCI.2769-09.2009.

45.

Keratinocytes acting on injured afferents induce extreme neuronal hyperexcitability and chronic pain.

Radtke C, Vogt PM, Devor M, Kocsis JD.

Pain. 2010 Jan;148(1):94-102. doi: 10.1016/j.pain.2009.10.014. Epub 2009 Nov 22.

PMID:
19932564
46.

Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia.

Zheng W, Honmou O, Miyata K, Harada K, Suzuki J, Liu H, Houkin K, Hamada H, Kocsis JD.

Brain Res. 2010 Jan 15;1310:8-16. doi: 10.1016/j.brainres.2009.11.012. Epub 2009 Nov 12.

PMID:
19913518
47.

Convergence of cells from the progenitor fraction of adult olfactory bulb tissue to remyelinating glia in demyelinating spinal cord lesions.

Markakis EA, Sasaki M, Lankford KL, Kocsis JD.

PLoS One. 2009 Sep 29;4(9):e7260. doi: 10.1371/journal.pone.0007260.

48.

Peripheral glial cell differentiation from neurospheres derived from adipose mesenchymal stem cells.

Radtke C, Schmitz B, Spies M, Kocsis JD, Vogt PM.

Int J Dev Neurosci. 2009 Dec;27(8):817-23. doi: 10.1016/j.ijdevneu.2009.08.006. Epub 2009 Aug 21.

PMID:
19699793
49.

Chapter 22: Transplantation of olfactory ensheathing cells for peripheral nerve regeneration.

Radtke C, Kocsis JD, Vogt PM.

Int Rev Neurobiol. 2009;87:405-15. doi: 10.1016/S0074-7742(09)87022-0. Review.

PMID:
19682651
50.

Unique in vivo properties of olfactory ensheathing cells that may contribute to neural repair and protection following spinal cord injury.

Kocsis JD, Lankford KL, Sasaki M, Radtke C.

Neurosci Lett. 2009 Jun 12;456(3):137-42. doi: 10.1016/j.neulet.2008.08.093. Epub 2009 Jan 17. Review.

Supplemental Content

Loading ...
Support Center